Transcription termination factor 2 (TTF2) prevents premature rRNA synthesis during mitotic exit
Life Science Alliance · 2026
DOI: 10.26508/lsa.202603841 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Science Alliance, 2026. Verfasst von Catarina Pedro und 4 weiteren Autor:innen. Beteiligte Einrichtung: Católica Biomedical Research Centre (CBR), Católica Medical School, Universidade Católica Portuguesa (UCP), Lisbon, Portugal. Hauptthemen laut MEDLINE: Mitosis, RNA, Ribosomal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MEC | Fundação para a Ciência e a Tecnologia, EC | European Research Council, EC | Horizon Europe | WPSERA | HORIZON EUROPE Widening participation and spreading excellence.
Abstract (Originalsprache)
Mitosis poses major challenges to transcription, as gene expression is silenced and must be restored upon mitotic exit. These processes are regulated by Cdk1-dependent phosphorylation. Additional mechanisms, including transcription termination factor 2 (TTF2)–mediated removal of nascent transcripts, reinforce transcriptional shutdown. How these regulatory layers control different RNA polymerases and influence reactivation at mitotic exit remains poorly understood. Here, we probed how TTF2 controls transcription of distinct RNA classes, using polymerase-specific perturbations and nascent RNA labelling across mitosis. Loss of TTF2 led to accumulation of chromatin-associated transcripts during metaphase, predominantly RNA polymerase II–derived, consistent with its role in transcriptional clearance. Unexpectedly, TTF2 depletion caused premature RNA polymerase I reactivation during anaphase, resulting in unscheduled rRNA synthesis and early nucleolar protein recruitment. These findings place TTF2 as a novel regulator of RNA polymerase I reactivation at mitotic exit. Disruption of this control persists beyond mitosis, resulting in nucleolar fragmentation in interphase. These findings reveal TTF2 as an important regulator that interfaces with multiple RNA polymerases through distinct modes, coordinating transcriptional shutdown and timely reactivation across mitosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Católica Biomedical Research Centre (CBR), Católica Medical School, Universidade Católica Portuguesa (UCP), Lisbon, Portugal.
- Gulbenkian Institute for Molecular Medicine (GIMM), Oeiras, Portugal.
- Católica Biomedical Research Centre (CBR), Católica Medical School, Universidade Católica Portuguesa (UCP), Lisbon, Portugal raaoliveira@ucp.pt.
ORCID-Profile: Catarina Pedro, Laura Tovini, Catarina Peneda, Raquel A Oliveira
Förderung
- MEC | Fundação para a Ciência e a Tecnologia
- EC | European Research Council
- EC | Horizon Europe | WPSERA | HORIZON EUROPE Widening participation and spreading excellence
Zitieren
APA
Pedro, C., Tovini, L., Peneda, C., Krapinec, M. M., & Oliveira, R. A. (2026). Transcription termination factor 2 (TTF2) prevents premature rRNA synthesis during mitotic exit. Life Science Alliance. https://doi.org/10.26508/lsa.202603841
Vancouver
Pedro C, Tovini L, Peneda C, Krapinec MM, Oliveira RA. Transcription termination factor 2 (TTF2) prevents premature rRNA synthesis during mitotic exit. Life Science Alliance. 2026. doi:10.26508/lsa.202603841
BibTeX
@article{Pedro2026,
author = {Pedro, Catarina and Tovini, Laura and Peneda, Catarina and Krapinec, Mia Maesano and Oliveira, Raquel A},
title = {Transcription termination factor 2 (TTF2) prevents premature rRNA synthesis during mitotic exit},
journal = {Life Science Alliance},
year = {2026},
doi = {10.26508/lsa.202603841}
}
EUVIMED